Skip to main content

Hepion Pharmaceuticals, Inc.

HEPA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001583771

In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Other share classesCTRVP

Superinvestors holding HEPA, Q2 2026

See all superinvestors

No superinvestor reported holding HEPA in Q2 2026.